PTC THERAPEUTICS, INC. — Director's Dealing 2020

Jan 9, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2020-01-06

Reporting Person: Almstead Neil Gregory (Chief Technical Ops Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-01-06	Common Stock	S	507	$48.168	Disposed	16889	Direct
2020-01-06	Common Stock	S	70	$48.168	Disposed	6149	Indirect
2020-01-06	Common Stock	S	57	$48.168	Disposed	6092	Indirect
2020-01-07	Common Stock	S	59	$49.621	Disposed	6033	Indirect

Footnotes

F1: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 1,500 shares of restricted stock from a January 3, 2017 grant of 6,000 shares of restricted stock.

F2: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 219 RSUs from a January 3, 2018 grant of 874 RSUs

F3: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 180 RSUs from a January 3, 2017 grant of 720 RSUs.

F4: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 188 RSUs from a January 4, 2016 grant of 750 RSUs.